Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiangsha Yangwei is a classic Traditional Chinese Medicine (TCM) formula primarily used to treat gastrointestinal disorders characterized by "dampness-cold" in the stomach and spleen. It is commonly indicated for functional dyspepsia, postprandial distress syndrome, chronic gastritis, and symptoms such as abdominal distension, loss of appetite, and nausea. The formula typically consists of multiple herbal ingredients, including *Aucklandia lappa* (Xiangmuxiang) and *Amomum villosum* (Sharen), which work synergistically to warm the middle burner, regulate Qi, and harmonize the stomach. It is widely manufactured in various forms, most notably as concentrated pills (Wan).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiangsha Yangwei.